featured
Axicabtagene Ciloleucel: Outcomes and Correlates of Response, Resistance, and Toxicity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
J. Clin. Oncol 2020 Jul 15;[EPub Ahead of Print], CA Jacobson, BD Hunter, R Redd, SJ Rodig, PH Chen, K Wright, M Lipschitz, J Ritz, Y Kamihara, P Armand, S Nikiforow, M Rogalski, J Maakaron, S Jaglowski, MV Maus, YB Chen, JS Abramson, J Kline, E Budde, A Herrera, M Mei, JB Cohen, SD Smith, DG Maloney, AK Gopal, MJ Frigault, UH AcharyaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.